SALTO - Epidemiological Study on Compliance and Treatment Satisfaction
Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two consecutive weeks. Patients will be instructed to follow treatment recommendations (either LMWH or oral treatment, at physician discretion) and to come back to the surgeon after that period. At that visit, the Treatment Satisfaction Questionaire with Medication (TSQM) test as well as the Moriski-Green Questionaire (measures compliance with medication) will be answer by the patient. TSQM is an self administered validated scale (validated also in spanish) that measures in a generic way the treatment satisfaction to a treatment. Morinski-Green test will be used to measure the compliance degree on medication.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Compliance and Treatment Satisfaction in Prophylaxis of Postsurgical Thromboembolism|
- To measure the Treatment Satisfaction with medication through the self administered scale TSQM. [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
- To measure compliance with medication and the relationship with satisfaction through the Moriski-Green Questionaire [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||November 2008|
|Study Completion Date:||March 2009|
|Primary Completion Date:||March 2009 (Final data collection date for primary outcome measure)|
Behavioral: No Drug
Patients in daily life clinical treatment receiving pharmacological agents to prevent VTE.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00911001
|Many Locations, Spain|
|Study Director:||Bayer Study Director||Bayer|